Levy, Elad I.
Mokin, Maxim
Article History
First Online: 24 February 2017
Competing interests
: E.I.L. has shareholder/ownership interests in Blockade Medical, Intratech Medical and NeXtGen Biologics. He serves as a national principal investigator for the Covidien US SWIFT PRIME Trials and receives honoraria for training and lecturing from Covidien. He receives compensation from Abbott for carotid training sessions for physicians. He serves as a consultant to Pulsar and Blockade Medical and on the Acute Ischemic Stroke Clinical Advisory Board for Stryker and the Advisory Board for NeXtGen Biologics and MEDX. M.M. declares no competing interests.